Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-08-001707
Filing Date
2008-03-11
Accepted
2008-03-11 17:09:45
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 IDERA PHARMACEUTICALS, INC. b68194ipe10vk.htm 10-K 1054062
2 EX-10.8 NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM EFFECTIVE JANUARY 1, 2008 b68194ipexv10w8.htm EX-10.8 4418
3 EX-10.31 CONSULTING AGREEMENT BETWEEN (KARR PHARMA CONSULTING, LLC) b68194ipexv10w31.htm EX-10.31 16518
4 EX-10.45 LICENSE AGREEMENT BETWEEN (MERCK KGAA) b68194ipexv10w45.htm EX-10.45 298682
5 EX-23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNNTING FIRM b68194ipexv23w1.htm EX-23.1 1783
6 EX-31.1 SECTION 302 CERTIFICATION OF CEO b68194ipexv31w1.htm EX-31.1 8576
7 EX-31.2 SECTION 302 CERTIFICATION OF CFO b68194ipexv31w2.htm EX-31.2 8594
8 EX-32.1 SECTION 906 CERTIFICATION OF CEO b68194ipexv32w1.htm EX-32.1 3172
9 EX-32.2 SECTION 906 CERTIFICATION OF CFO b68194ipexv32w2.htm EX-32.2 3631
10 GRAPHIC b68194ipb6819401.gif GRAPHIC 4349
  Complete submission text file 0000950135-08-001707.txt   1407077
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31918 | Film No.: 08681409
SIC: 2836 Biological Products, (No Diagnostic Substances)